The conference will bring together a large number of high-level experts and stakeholders with different background and expertise, from different types of organisations and countries, including from outside Europe, to discuss challenges and opportunities in the field of genomic-based personalised medicine, as well as aspects not covered in research and funding.

The 10th Panhellenic Conference of Biomedical Technology will host a poster presentation on eCAN Joint Action next Friday 6th of October.

Each year, the European Federation of Medical Informatics (EFMI) holds a Special Topic Conference (STC). In 2023, the main focus is telehealth Ecosystems in Practice and conference topics will include homecare and telemonitoring, televisits, teleradiology, telerehabilitation, data integration and standards, sensors, devices and Patient Reported Outcomes, AI applications to telehealth, healthbots and conversational agents and, […]

The Research Ethics and Ethics Committee of the University of Thessaly is organizing a conference in Greek entitled "Current issues of Ethics and Ethics with an emphasis on clinical trials and artificial intelligence". The event will host scientists from the field of Ethics and Ethics, under the coordination of faculty members of the University of Thessaly. The aim of the conference is to inform and exchange documented opinions as well as the interaction between scientists on current issues of ethics and ethics in research.

The European Public Health (EPH) Conference is an annually organised scientific conference on public health issues in Europe. Each year the conference is organised in a different country by the EPH Conference Foundation in close cooperation with one or more local partner(s). The conference actively seeks a larger partnership with other European NGOs and institutions.

eCAN will attend this meeting to present the aims and objectives of the project after its first year of existence. The National Oncology Conference BJCN-MORE 2023 is devoting its experts, digital evangelists and listeners to clinical behavior in esophageal and gastroesophageal junction carcinoma.